(19)

(11)

EP 4 298 234 A1

(12)

(43) Date of publication: 03.01.2024 Bulletin 2024/01 (21) Application number: 21928290.2 (22) Date of filing: 25.02.2021

(51) International Patent Classification (IPC):  C12Q 1/32(2006.01) C12Q 1/00(2006.01) C12Q 1/26(2006.01) B01L 3/00(2006.01) (52) Cooperative Patent Classification (CPC): C12Q 1/32; C12Q 1/26; C12Q 1/004; C12Q 1/005; G01N 2333/90212; G01N 2333/90209; G01N 27/3272 (86) International application number: PCT/US2021/019515 (87) International publication number: WO 2022/182344 (01.09.2022 Gazette 2022/35)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (71) Applicant: Nova Biomedical Corporation Waltham, MA 02454 (US)	(72) Inventors: PEI, Jianhong Somerville, Massachusetts 02145 (US) BEDARD, Joseph Waltham, Massachusetts 04553 (US) TRAM, Aaron Weymouth, Massachusetts 02190 (US) MOSLEY, Samantha Hyde Park, Massachusetts 02136 (US) YOUNG, Chung Chang Salem, New Hampshire 03079 (US) (74) Representative: Prinz & Partner mbB  Patent- und Rechtsanwälte Rundfunkplatz 2 80335 München 80335 München (DE)